Citral and testosterone interactions in inducing benign and atypical prostatic hyperplasia in rats

Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology

Volumn 115, Issue 2, 1996, Pages 169-177

  Engelstein, Dov ^a,d   Shmueli, Joseph ^a   Bruhis, Sela ^b   Servadio, Ciro ^a   Abramovici, Armand ^c  

^a Institute of Urology   (Israel)

^b Endocrinology Laboratory B   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

circadian; citral; hyperplasia; prostate; rat; testosterone

Indexed keywords

CITRAL; TESTOSTERONE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; MALE; MONOTERPENES; ORCHIECTOMY; PROSTATE; PROSTATIC HYPERPLASIA; RATS; RATS, WISTAR; TERPENES; TESTOSTERONE;

EID: 0030267155     PISSN: 07428413     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0742-8413(96)00057-6     Document Type: Article

References (36)

1. 1. Abramovici, A.; Kam, J.; Liban, E.; Barishak, R.Y. Incipient histopathological lesions in citral-induced microphthalmos in chick embryos. Dev. Neurosci. 1:177-185;1978.
2. 2. Abramovici, A.; Rachmut-Roizman, P. Molecular structure-teratogenicity relationship of some fragrance activities. Toxicology 29:143-156;1983.
3. 3. Abramovici, A.; Servadio, C.; Sandbank, U. Benign hyperplasia in rats induced by a monoterpene. Prostate 7:389-394; 1985.
4. 4. Abramovici, A.; Servadio, C.; Shmuely, J.; Sandbank, U. Experimental induction of atypical hyperplasia in rat ventral prostate. In: Murphy, G.P.; Khoury, S.; Kuss, P.; Chatelain, C.; Denis, L. (eds). Prostate cancer, Part A: Research, endocrine treatment and histopathology. New York: Alan R. Riss, Inc; 1987:559-568.
5. 5. Bartke, A.; Steele, R.E.; Musto, N.; Caldwell, B.V. Fluctuations in plasma testosterone levels in adult male rats and mice. Endocrinology 92:1223-1228;1973.
6. 6. Bedoukian, P.Z. Perfumery and flavoring synthetics, 2nd ed. Amsterdam: Elsevier; 1967:99-111.
7. 7. Berry, S.J.; Coffey, D.S.; Strandberg, J.D.; Ewing, L.L. Effect of age, castration and testosterone replacement on the development and restoration of canine benign prostatic hyperplasia. Prostate 9:295-302;1986.
8. 8. Bremner, W.J.; Vitiello, M.V.; Prinz, P.N. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J. Clin. Endocrinol. Metab. 56:1278-1281;1983.
9. 9. Brolin, J.; Skoog, L.; Ekman, P. Immunohistochemistry and biochemistry in detection of androgen, progesterone and estrogen receptors in benign and malignant human prostatic tissue. Prostate 20:281-295;1992.
10. 10. Cardullo, A.C.; Ruszkovski, A.N.; DeLeo, V.A. Allergic contact dermatitis resulting from sensitivity to citrus peel, geraniol and citral. J. Am. Acad. Dermatol. 21:395-397;1989.
11. 11. Coffey, D.S. The molecular biology, endocrinology and physiology of the prostate and seminal vesicles. In: Walsh, P.C.; Retik, A.B.; Stamey, T.A.; Vaughan, Jr., E.D. (eds). Campbell's urology. Philadelphia: Saunders; 1992:221-251.
12. 12. Coffey, D.S.; Walsh, P.C. Clinical and experimental studies of benign prostatic hyperplasia. Urol. Clin. North Am. 17: 461-475;1990.
13. 13. Dziuk, P.J.; Cook, B. Passage of steroids through silicone rubber. Endocrinology 78:208-211;1966.
14. 14. Frank, L.M. Normal and pathological anatomy and histology of the genital tracts of rats and mice. In: Cotchin, E.; Roe, F.J.C. (eds). Pathology of laboratory rats and mice. Oxford: Blackwell Scientific Publications; 1967:469-499.
15. 15. Geldof, A.A.; Engel, C.; Rao, B.R. Estrogenic action of commonly used fragrant agent citral induces prostatic hyperplasia, Urol. Res. 20:139-144;1992.
16. 16. Hanau, D.; Grosshane, E.; Barbier, P.; Benezra, C. The influence of limonene on induced delayed hypersensitivity to citral in guinea pigs. I. Histological study. Acta Dermatol. Venereol. (Stockh) 6:1-7;1983.
17. 17. Ho, S.; Leav, I.; Merk, F.B.; Yu, M.; Kwan, PW-L.; Ziar, J. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostate of noble rats treated with testosterone and pharmacologic doses of estradiol-17β. Lab Invest 73:356-365;1995.
18. 18. Karr, J.P.; Kim, U.; Resko, J.A.; Schneider, S.; Chai, L.S.; Murphy, G.P.; Sandbery, A.A. Induction of benign prostatic hypertrophy in baboons. Urology 23:276-289;1984.
19. 19. Keating, R.J.; Tcholakian, R.K. In vivo patterns of circulating steroids in adult male rats. I. Variations in testosterone during 24-and 48-hour standard and reverse light/dark cycles. Endocrinology 104:184-188;1979.
20. 20. Lillie, R.D. Histopathologic technique and practical histochemistry. 3rd ed. New York: McGraw-Hill; 1965:48-49.
21. 21. Mock, E.J.; Norton, H.W.; Frankel, A.I. Daily rhythmicity of serum testosterone concentration in male laboratory rats. Endocrinology 103:1111-1121;1978.
22. 22. Moleyar, V.; Narasimhan, P. Antimicrobial activity of essential oil components. Int. J. Food Microbiol. 16:337-342;1992.
23. 23. Naslund, M.J.; Coffey, D.S. The differential effects of neonatal androgens, estrogen and progesterone on adult rat prostate growth. J. Urol. 136:1136-1140;1986.
24. 24. Noble, R.L. Production of Nb rat carcinoma of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen. Cancer Res. 40:3547-3550;1980.
25. 25. Ofner, P.; Bosland, M.C.; Vena, R.L. Differential effects of diethylstibestrol and estradiol-17β in combination with testosterone on rat prostate lobes. Toxicol. Appl. Pharmacol. 112:300-309;1992.
26. 26. Opdyke, D.L.J. Monographs on fragrances raw materials. Food Cosmet. Toxicol. 17:241-275;1979.
27. 27. Pearse, A.G.E. Histochemistry, theoretical and applied, 4th ed. London: Churchill Livingstone; 1980.
28. 28. Pour, P.M. A new prostatic cancer model: Systemic induction of prostatic cancer in rats by mitrosamine. Cancer Lett. 13: 303-308;1981.
29. 29. Robaire, B.; Ewing, L.L.; Irby, D.C.; Desjardins, C. Interactions of testosterone and estradiol-17 beta on the reproductive tract of the male rat. Biol. Reprod. 21:455-463;1979.
30. 30. Sandbank, M.; Abramovici, A.; Wolf, R.; Ben David, E. Sebaceous gland hyperplasia following topical application of citral. Am. J. Dermatopathol. 10:415-418;1988.
31. 31. Schroeder, F.H. Current models and their relation to human diseases. In: Hinman F, ed. Benign prostatic hypertrophy. New York: Springer Verlag; 1983:215-228.
32. 32. Servadio, C.; Abramovici, A.; Sandbank, U.; Savion, M.; Rosen, M. Early stages of the pathogenesis of rat ventral prostate hyperplasia induced by citral. Eur. Urol. 12:195-200;1986.
33. 33. Shain, S.A.; McCullough, B.; Sagaloff, A. Spontaneous adenocarcinoma of the ventral prostate of aged AXC rats. J. Natl. Cancer Inst. 55:177-180;1975.
34. 34. Tamir, I.; Abramovici, A.; Milo-Goldzweig, I.; Segal, R. The hemolytic activity of citral. I. Evidence for free radical participation. Biochem. Pharmacol. 33:2945-2950;1984.
35. 35. Thomas, J.A.; Keenan, E. Effects of estrogen on the prostate. J. Androl. 15:97-99;1994.
36. 36. Walvoord, D.J.; Resnick, M.I.; Grayhack, J.T. Effect of testosterone, dihydrotestosterone, estradiol and prolactin on the weight and citric acid content of the lateral lobe of the rat prostate. Invest. Urol. 14:60-65;1976.